Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Solivite is a specialized nutritional supplement developed by Blue Heron Pharmaceuticals, specifically engineered for the dietary management of patients with malabsorption disorders, most notably cystic fibrosis. The product addresses the common challenge of fat-soluble vitamin deficiency in these populations by providing vitamins A, D, E, and K in a water-miscible or micellar form, which enhances bioavailability in the absence of adequate bile salts or pancreatic enzymes. In addition to fat-soluble vitamins, Solivite contains a comprehensive profile of B-complex vitamins and essential minerals like zinc and selenium. It is marketed as a medical food or high-potency supplement to maintain nutritional status and prevent the systemic complications associated with chronic micronutrient malabsorption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Solivite.